Aptevo Therapeutics Stock Quote APVO - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.166

Bid

0.1659

Ask

0.166

Volume

29,264

0.00 Day's Range 0.00

0.141 52 Week Range 21.56

Market Cap

1.564M

Previous Close

0.1646

Open

Last Trade

0.166

Last Trade Time

06:31:14

Financial Volume

VWAP

Average Volume (3m)

6,953,541

Shares Outstanding

9,420,489

Dividend Yield

PE Ratio

-0.09

Earnings Per Share (EPS)

-1.85

Revenue

Net Profit

-17.41M

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aptevotherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

Aptevo Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker APVO. The last closing price for Aptevo Therapeutics was $0.16. Over the last year, Aptevo Therapeutics shares have traded in a share price range of $ 0.141 to $ 21.56.

Aptevo Therapeutics currently has 9,420,489 shares outstanding. The market capitalization of Aptevo Therapeutics is $1.55 million. Aptevo Therapeutics has a price to earnings ratio (PE ratio) of -0.09.

Form 8-K - Current report

FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1941	-53.9016939739	0.3601	0.379	0.141	8020772	0.28590348	CS
4	-0.214	-56.3157894737	0.38	0.4202	0.141	2195507	0.28889425	CS
12	-0.3417	-67.3035257042	0.5077	0.6559	0.141	6953541	0.52899492	CS
26	-5.004	-96.7891682785	5.17	5.5	0.141	3604717	0.6042556	CS
52	-16.114	-98.9803439803	16.28	21.56	0.141	2063680	1.7198726	CS
156	-748.274	-99.9778205334	748.44	971.5156	0.141	1114197	197.6305435	CS
260	-29.314	-99.4369063772	29.48	2640	0.141	863426	274.19765923	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ZEOZeo Energy Corporation	$ 3.70 (224.56%)	3.17M
XCURExicure Inc	$ 6.65 (190.39%)	3.07M
TBIOTelesis Bio Inc	$ 3.65 (168.38%)	4.6M
VEROVenus Concept Inc	$ 0.8303 (65.23%)	3.18M
VMARVision Marine Technologies Inc	$ 0.861 (42.79%)	4.15M
BNRBurning Rock Biotech Ltd	$ 1.51 (-56.66%)	3
PGNYProgyny Inc	$ 17.57 (-28.11%)	65.05k
ATMCAlphaTime Acquisition Corporation	$ 9.00 (-19.64%)	10
WBUYWeBuy Global Ltd	$ 0.1541 (-16.39%)	549.02k
CUTRCutera Inc	$ 0.64 (-16.05%)	13
FRGTFreight Technologies Inc	$ 0.1734 (39.95%)	24.89M
MAXNMaxeon Solar Technologies Ltd	$ 0.1053 (15.84%)	11.63M
TBIOTelesis Bio Inc	$ 3.65 (168.38%)	4.6M
VMARVision Marine Technologies Inc	$ 0.861 (42.79%)	4.15M
VEROVenus Concept Inc	$ 0.8303 (65.23%)	3.18M